Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Non-Current Deffered Revenue (2018 - 2020)

Updated

Astrazeneca's Non-Current Deffered Revenue was $38 million in Q4 2020, down 24.0% from $50 million a year earlier.

Analysis

Astrazeneca (AZN) Non-Current Deffered Revenue (2018 - 2020) Analysis & Trends

  • In earlier years, Non-Current Deffered Revenue was $50 million in FY2019 (-35.9%) and $78 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 38.00 Mn
Dec 31, 2019 50.00 Mn
Dec 31, 2018 78.00 Mn
API Access

Astrazeneca Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY